Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity (Details 3)

v3.20.2
Shareholders Equity (Details 3) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Equity [Abstract]        
Research and development expenses, net $ 310 $ 173 $ 502 $ 367
General and administrative 367 154 512 264
Share-based payment expenses, total $ 677 $ 327 $ 1,014 $ 631